With antibiotic-resistant gonorrhea on the rise, the vaccine could provide a way to prevent the disease from spreading.

Stocks from pharmaceutical companies and healthcare spaces dominated analysts' choices for Thursday's trading session.

Turning thet tide against tuberculosis . As the world's deadliest infectious disease surges, GSK and partners are pioneering ...

Depemokimab reduces exacerbations regardless of baseline asthma control, suggesting uncontrolled symptoms are not necessary ...

Nifty Pharma stocks, including GSK, Jubilant Pharmova, Eris Life, Gland Pharma and Torrent Pharma, saw gains up to 8% as ...

Tezepelumab, a monoclonal antibody targeting TSLP approved for add-on severe asthma treatment in 2021, had been associated ...

Microsoft launches Discovery, its new enterprise AI platform from Build 2025, set to accelerate scientific R&D via collaborative AI agents & a graph-knowledge engine for faster innovation.

Current treatment paradigms for lupus nephritis offer significant room for improvement, according to a presenter at the ...

Microsoft launches Discovery platform that uses agentic AI to compress years of scientific research into days, transforming R ...

Microsoft Corp. today announced the launch of Microsoft Discovery, a new enterprise-grade artificial intelligence platform ...

A low-carbon version of a triple combination pMDI inhaler indicated for adults with moderate-to-severe COPD has been approved by the MHRA.